<DOC>
	<DOCNO>NCT01200186</DOCNO>
	<brief_summary>Prospective , non-interventional , multi-center study . Each subject follow twelve month treatment oral hormonal contraceptive ( Qlaira ® Progestin Only Pill ) . For subject demographic data medical history document Visit 1 : ( Baseline ) . Bleeding profile , subjective assessment study treatment ( satisfaction wellbeing ) adverse event include unintended pregnancy document Visit 2 ( Month 3-5 ) Visit 3 ( Month 6-12 ) . Data audit/monitoring do .</brief_summary>
	<brief_title>Non-interventional Study Oral Contraception Not Containing Ethinylestradiol ( EE ) Assess Continuation Rates Satisfaction</brief_title>
	<detailed_description />
	<mesh_term>Ethinyl Estradiol</mesh_term>
	<mesh_term>Progestins</mesh_term>
	<criteria>Women 1850 year Women use ethinylestradiol contain oral contraceptive least three precede month study Women decide start Qlaira® Progestin Only Pill . The prescription hormonal contraceptive make discretion attend physician documented Contraindications warning respective Summary Product Characteristics ( Qlaira® Progestin Only Pill ) Women breastfeed</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>October 2015</verification_date>
</DOC>